Basic Information
RNALocate ID: RLID:11002413
RNA Symbol: hsa-miR-30e-3p
Localization: Microvesicle
RNA Information
RNA Name: hsa-miR-30e-3p
RNA ID: miRBase:MIMAT0000693
RNA Category: miRNA
Species: Homo sapiens
Sequence:
Localization Information
PubMed ID: 24797360
Tissue/Cell Line: Serum
Method: RNA sequencing
Description: Differentially expressed miRNAs detected in the serum (SER). Data are collected from Table 2.
Other Subcellular Localization
RNALocate ID Localization Tissue/Cell line PubMed ID
RLID:01002007 Mitochondrion Skeletal muscle myoblasts 21637849
RLID:01002008 Mitochondrion Cell line (HEK-293|HeLa) 22984580
RLID:11002406 Exosome Primary dendritic cells|T cell line (J77) 21505438
RLID:11002407 Exosome Breast milk 22211110
RLID:11002408 Exosome Brain tissue 23382797
RLID:11002409 Exosome Plasma 23663360
RLID:11002410 Exosome Human mast cell line (HMC-1) 24009880
RLID:11002411 Microvesicle Seminal plasma 23539611
RLID:11002412 Microvesicle Follicular fluid 23666971
RLID-D:11000116 Exosome B lymphoblastoid cells|Chronic lymphocytic leukemia cells|Endothelial cells|Lymphoma tissue|Mast cells
RLID-D:11000405 Microvesicle Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine
ncRNA Disease Information
Resource RNA Symbol Disease Link
MNDR hsa-miR-30e-3p Multiple sclerosis chronic progressive MNDR-E-MI-37636
MNDR hsa-miR-30e-3p Oral squamous cell carcinoma MNDR-E-MI-37637
MNDR hsa-miR-30e-3p Large cell neuroendocrine cancer MNDR-E-MI-37638
MNDR hsa-miR-30e-3p Lymphoma MNDR-E-MI-37639
MNDR hsa-miR-30e-3p Estrogen-receptor positive breast cancer MNDR-E-MI-37640
MNDR hsa-miR-30e-3p Estrogen-receptor negative breast cancer MNDR-E-MI-37641
MNDR hsa-miR-30e-3p Progesterone-receptor positive breast cancer MNDR-E-MI-37642
MNDR hsa-miR-30e-3p Progesterone-receptor negative breast cancer MNDR-E-MI-37643
MNDR hsa-miR-30e-3p Her2-receptor positive breast cancer MNDR-E-MI-37644
MNDR hsa-miR-30e-3p Niemann-pick disease type c MNDR-E-MI-37645
MNDR hsa-miR-30e-3p Dermatomyositis MNDR-E-MI-37646
MNDR hsa-miR-30e-3p Prostate cancer MNDR-E-MI-37647
MNDR hsa-miR-30e-3p Gastric cancer MNDR-E-MI-37648
MNDR hsa-miR-30e-3p Gastric lymphoma MNDR-E-MI-37649
MNDR hsa-miR-30e-3p Alzheimer disease MNDR-E-MI-37650
MNDR hsa-miR-30e-3p Intracranial aneurysm MNDR-E-MI-37651
MNDR hsa-miR-30e-3p Esophageal carcinoma MNDR-E-MI-37652
MNDR hsa-miR-30e-3p Head and neck cancer MNDR-E-MI-37653
MNDR hsa-miR-30e-3p Cardiovascular disease MNDR-E-MI-37654
MNDR hsa-miR-30e-3p Lung cancer MNDR-E-MI-37655
MNDR hsa-miR-30e-3p Parkinson disease MNDR-E-MI-37656
MNDR hsa-miR-30e-3p Niemann-pick disease MNDR-E-MI-37657
MNDR hsa-miR-30e-3p Basal-like breast cancer MNDR-E-MI-37658
MNDR hsa-miR-30e-3p Thyroid cancer MNDR-E-MI-37659
MNDR hsa-miR-30e-3p Pancreatic cancer MNDR-E-MI-37660
MNDR hsa-miR-30e-3p Melanoma MNDR-E-MI-37661
MNDR hsa-miR-30e-3p Rectum adenocarcinoma MNDR-E-MI-37662
MNDR hsa-miR-30e-3p Nephroblastoma MNDR-E-MI-37663
MNDR hsa-miR-30e-3p Colon cancer MNDR-E-MI-37664
MNDR hsa-miR-30e-3p Ischemic attack transient MNDR-E-MI-37665
MNDR hsa-miR-30e-3p Colon adenocarcinoma MNDR-E-MI-37666
MNDR hsa-miR-30e-3p West nile virus infection MNDR-E-MI-37667
MNDR hsa-miR-30e-3p Multiple sclerosis relapsing-remitting MNDR-E-MI-37668
MNDR hsa-miR-30e-3p Familial ovarian cancer MNDR-E-MI-37669
MNDR hsa-miR-30e-3p Prostate adenocarcinoma MNDR-E-MI-37670
MNDR hsa-miR-30e-3p Carcinoma ductal breast MNDR-E-MI-37671
MNDR hsa-miR-30e-3p Glioblastoma MNDR-E-MI-37672
MNDR hsa-miR-30e-3p Glioma MNDR-E-MI-37673
MNDR hsa-miR-30e-3p Amyotrophic lateral sclerosis MNDR-E-MI-37674
MNDR hsa-miR-30e-3p Osteosarcoma MNDR-E-MI-37675
MNDR hsa-miR-30e-3p Inclusion body myositis MNDR-E-MI-37676
MNDR hsa-miR-30e-3p Meningioma MNDR-E-MI-37677
MNDR hsa-miR-30e-3p Gastric adenocarcinoma MNDR-E-MI-37678
MNDR hsa-miR-30e-3p Cervical squamous cell carcinoma MNDR-E-MI-37679
MNDR hsa-miR-30e-3p Bone-invasive pituitary adenoma MNDR-E-MI-37680
MNDR hsa-miR-30e-3p Lung squamous cell carcinoma MNDR-E-MI-37681
MNDR hsa-miR-30e-3p Lung adenocarcinoma MNDR-E-MI-37682
MNDR hsa-miR-30e-3p Thyroid carcinoma MNDR-E-MI-37683
MNDR hsa-miR-30e-3p Bladder urothelial carcinoma MNDR-E-MI-37684
MNDR hsa-miR-30e-3p Carcinoma renal cell MNDR-E-MI-37685
MNDR hsa-miR-30e-3p Kidney renal papillary cell carcinoma MNDR-E-MI-37686
MNDR hsa-miR-30e-3p Clear cell renal cell carcinoma MNDR-E-MI-37687
MNDR hsa-miR-30e-3p Large cell carcinoma MNDR-E-MI-37688
MNDR hsa-miR-30e-3p Cholangiocarcinoma MNDR-E-MI-37689
MNDR hsa-miR-30e-3p Esophageal cancer MNDR-E-MI-37690
MNDR hsa-miR-30e-3p Lung small cell carcinoma MNDR-E-MI-37691
MNDR hsa-miR-30e-3p Head and neck squamous cell carcinoma MNDR-E-MI-37692
MNDR hsa-miR-30e-3p Testicular germ cell cancer MNDR-E-MI-37693
MNDR hsa-miR-30e-3p Breast invasive carcinoma MNDR-E-MI-37694
MNDR hsa-miR-30e-3p Hepatocellular carcinoma MNDR-E-MI-37695
MNDR hsa-miR-30e-3p Familiar ovarian carcinoma MNDR-E-MI-37696
MNDR hsa-miR-30e-3p Rheumatoid arthritis MNDR-E-MI-37697
MNDR hsa-miR-30e-3p Malignant pleural mesothelioma MNDR-E-MI-37698
MNDR hsa-miR-30e-3p Barrett's adenocarcinoma MNDR-E-MI-37699
MNDR hsa-miR-30e-3p Hodgkin lymphoma MNDR-E-MI-37700
MNDR hsa-miR-30e-3p Tonsil cancer MNDR-E-MI-37701
MNDR hsa-miR-30e-3p Neuromyelitis optica MNDR-E-MI-37702
MNDR hsa-miR-30e-3p Colorectal cancer MNDR-E-MI-37703
MNDR hsa-miR-30e-3p Nasopharynx carcinoma MNDR-E-MI-37704
MNDR hsa-miR-30e-3p Cardiomegaly MNDR-E-MI-37705
MNDR hsa-miR-30e-3p Nasopharyngeal cancer MNDR-E-MI-37706
MNDR hsa-miR-30e-3p Wounds and injuries MNDR-E-MI-37707
MNDR hsa-miR-30e-3p Cerebral hemorrhage traumatic MNDR-E-MI-37708
MNDR hsa-miR-30e-3p Intracranial hemorrhage hypertensive MNDR-E-MI-37709
MNDR hsa-miR-30e-3p Peripheral nerve injuries MNDR-E-MI-37710
MNDR hsa-miR-30e-3p Chronic pain MNDR-E-MI-37711
MNDR hsa-miR-30e-3p Stroke lacunar MNDR-E-MI-37712
MNDR hsa-miR-30e-3p Barrett's carcinogenesis MNDR-E-MI-37713
MNDR hsa-miR-30e-3p Breast cancer her3+ negative MNDR-E-MI-37714
MNDR hsa-miR-30e-3p Duke C MNDR-E-MI-37715
RNA Interaction Information
Resource RNA Symbol Species Link RNALocate ID
RNAInter ATF3 Homo sapiens RR00155509
TOP